Elisan Pharma Llp - Company Profile

It is a pharma limited liability partnership based in Ratnagiri, Maharashtra, India, established in 2021.
2021 Ratnagiri, Maharashtra, India Active
Last Updated:
Access Report
About Elisan Pharma Llp

Elisan Pharma Llp, a active limited liability partnership, was established on 01 December 2021 in Ratnagiri, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds LLPIN: AAZ-7159. Registered under ROC Roc Pune. It has total obligation of contribution of ₹1.00 Cr.

Its leadership includes Alfaraz Ashraf Kapade (Designated Partner), Ashraf Abdulrahiman Kapade (Designated Partner). It holds ₹4.95 Cr open charges and no settled loans. Its latest date of accounts and solvency statement 31 March 2025. It is based at H.No. 1631, Plot No. X 28, Midc, Mirjole, Ratnagiri, Maharashtra, 415612.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAZ-7159

  • Incorporation Date

    01 December 2021

  • Total Obligation of Contribution

    ₹1.00 Cr

  • ROC Code

    Roc Pune

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 1.00 Cr
  • Company Age 4 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 4.95 Cr
Company report

Elisan Pharma Llp

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Elisan Pharma Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Elisan Pharma Llp?
Current Designated Partners
Name Designation Appointment Date Status
Alfaraz Ashraf Kapade Designated Partner 01 Dec 2021 Current
Ashraf Abdulrahiman Kapade Designated Partner 01 Dec 2021 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Elisan Pharma Llp.

Enhance accessibility to Elisan Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Elisan Pharma Llp revenue growth over time
Elisan Pharma Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Elisan Pharma Llp?

Unlock access to Elisan Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹49,500,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • State Bank Of India : 4.95 Cr
Latest Charge Details
Date Lender Amount Status
11 Feb 2022 State Bank Of India ₹4.95 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Elisan Pharma Llp?

Unlock and access historical data on people associated with Elisan Pharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Elisan Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elisan Pharma Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Elisan Pharma Llp
Recent Activity within the Organization
  • Annual General Meeting

    The activity Elisan Pharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was completed.

  • Statement of Assets & Liabilities

    Progress on Elisan Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was documented.

  • Charges

    A charge with State Bank Of India of Rs. 4.95 Cr registered on 11 Feb 2022 with Charge ID 100698635 was modified on 14 Mar 2024. was recorded as a recent event.

  • Charges

    A charge with State Bank Of India amounted to Rs. 4.95 Cr with Charge ID 100698635 was registered on 11 Feb 2022. was recorded as a recent event.

  • Director Appointment

    Alfaraz Ashraf Kapade was appointed as a Designated Partner was appointed as a Designated Partner on 01 Dec 2021 & has been associated with this company since 4 years 5 months . was recorded as a recent event.

  • Director Appointment

    Progress on Ashraf Abdulrahiman Kapade was appointed as a Designated Partner was appointed as a Designated Partner on 01 Dec 2021 & has been associated with this company since 4 years 5 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Elisan Pharma Llp?

The LLPIN of Elisan Pharma Llp is AAZ-7159.

Where is Elisan Pharma Llp headquartered?

Elisan Pharma Llp is headquartered at H.No. 1631, Plot No. X 28, Midc, Mirjole, Ratnagiri, Maharashtra, 415612.

When was Elisan Pharma Llp incorporated?

Elisan Pharma Llp was incorporated on 01 December 2021.

Who are the current directors of Elisan Pharma Llp?

The current directors of Elisan Pharma Llp are

What is the primary industry of Elisan Pharma Llp?

The primary industry of Elisan Pharma Llp is Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available